15 results
424B3
SCLX
Scilex Holding Company
2 Apr 24
Prospectus supplement
5:20pm
review and approval of products designated as regenerative advanced therapies. A product is eligible for this designation if it is a regenerative … indicates that the product candidate has the potential to address unmet medical needs for such disease or condition. The benefits of a regenerative
424B3
SCLX
Scilex Holding Company
2 Apr 24
Prospectus supplement
5:19pm
to accelerate review and approval of products designated as regenerative advanced therapies. A product is eligible for this designation if it is a regenerative … of a regenerative advanced therapy designation include early interactions with the FDA to expedite development and review, benefits available to breakthrough
POS AM
SCLX
Scilex Holding Company
27 Mar 24
Prospectus update (post-effective amendment)
5:30pm
in December 2016, Congress authorized the FDA to accelerate review and approval of products designated as regenerative advanced therapies. A product … is eligible for this designation if it is a regenerative medicine therapy that is intended to treat, modify, reverse or cure a serious or life
POS AM
SCLX
Scilex Holding Company
27 Mar 24
Prospectus update (post-effective amendment)
5:29pm
as regenerative advanced therapies. A product is eligible for this designation if it is a regenerative medicine therapy that is intended to treat, modify, reverse … to address unmet medical needs for such disease or condition. The benefits of a regenerative advanced therapy designation include early interactions
424B3
8bbrxe3emlivfqydpenl
19 Apr 23
Prospectus supplement
4:41pm
424B3
8dzrk169iven0hy
27 Dec 22
Prospectus supplement
5:19pm
424B3
92f0h3flh4cca2je71j
9 Dec 22
Prospectus supplement
5:16pm
- Prev
- 1
- Next